Short answer
Altimmune, Inc. (ALT) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 8.01 (Other Events). Headquarters relocation from Gaithersburg, Maryland to Morristown, New Jersey planned later in 2026.
Altimmune, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Headquarters relocation from Gaithersburg, Maryland to Morristown, New Jersey planned later in 2026
- Five-year office lease costs approximately $300,000 annually
- New location targets biopharmaceutical talent access for Altimmune’s hybrid operating model
- Management expects long-term cost efficiencies, but benefits remain forward-looking and uncertain
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Altimmune, Inc. 8-K filings
Get the next ALT 8-K as it lands
Follow ALT for push alerts, or ask the research agent what this filing means.